| scholarly article | Q13442814 |
| P50 | author | Robin Murray | Q7352679 |
| Rowena Handley | Q114406787 | ||
| Andrew S Papadopoulos | Q114431728 | ||
| Serena Navari | Q114452864 | ||
| Katherine J. Aitchison | Q37828818 | ||
| Annamaria Cattaneo | Q37830437 | ||
| Craig Morgan | Q39927282 | ||
| Martino Belvederi Murri | Q40573757 | ||
| Valeria Mondelli | Q42683658 | ||
| Paola Dazzan | Q46730140 | ||
| Marta Di Forti | Q46888593 | ||
| Carmine Pariante | Q49754517 | ||
| Nilay Hepgul | Q88679189 | ||
| P2093 | author name string | Ana Miorelli | |
| P2860 | cites work | Lasting epigenetic influence of early-life adversity on the BDNF gene | Q24600763 |
| Rapid reversal of psychotic depression using mifepristone | Q28191073 | ||
| Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription | Q28268028 | ||
| Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial | Q28283107 | ||
| Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment | Q28285951 | ||
| The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function | Q29615582 | ||
| A neurotrophic model for stress-related mood disorders | Q29616291 | ||
| Inflammatory Blockade Restores Adult Hippocampal Neurogenesis | Q29619037 | ||
| Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? | Q30695945 | ||
| Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies | Q31043017 | ||
| Environmental enrichment, exercise and corticosterone affect endothelial cell proliferation in adult rat hippocampus and prefrontal cortex | Q33351556 | ||
| Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior | Q33664173 | ||
| Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia | Q33847022 | ||
| Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation | Q33999992 | ||
| Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia | Q34098621 | ||
| The neurobiology of stress: from serendipity to clinical relevance | Q34105817 | ||
| Hippocampal volume change in schizophrenia | Q34116883 | ||
| Hippocampal volume in familial and nonfamilial schizophrenic probands and their unaffected relatives | Q34188722 | ||
| Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals | Q34492046 | ||
| Early social enrichment shapes social behavior and nerve growth factor and brain-derived neurotrophic factor levels in the adult mouse brain | Q34501661 | ||
| The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met | Q34608856 | ||
| PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers | Q34622380 | ||
| Childhood trauma associated with smaller hippocampal volume in women with major depression. | Q35591603 | ||
| Brain derived neurotropic factor in first-episode psychosis | Q35914742 | ||
| Cytokines and glucocorticoid receptor signaling. Relevance to major depression | Q36101717 | ||
| The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity | Q36254250 | ||
| The use of mifepristone in the treatment of neuropsychiatric disorders | Q36418572 | ||
| Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis | Q36442025 | ||
| Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment | Q36442033 | ||
| Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis | Q36442053 | ||
| Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings | Q36920685 | ||
| Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults | Q36925067 | ||
| Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review | Q37001984 | ||
| TNF-alpha as a molecular target in bipolar disorder | Q37100442 | ||
| Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis | Q40404354 | ||
| Systemic interleukin-1 beta decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation | Q40906890 | ||
| Physiology of the neurotrophins | Q41132669 | ||
| BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects | Q42475620 | ||
| Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial | Q42506457 | ||
| Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics | Q43009824 | ||
| Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. | Q43260112 | ||
| A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system | Q43754027 | ||
| Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia | Q44013100 | ||
| Effect of IL-1beta on CRE-dependent gene expression in human airway smooth muscle cells | Q44185692 | ||
| Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change | Q44533519 | ||
| Pituitary volume and early treatment response in drug-naïve first-episode psychosis patients. | Q45974373 | ||
| Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis | Q46059619 | ||
| An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression | Q46079014 | ||
| Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly | Q46604356 | ||
| BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects | Q46915507 | ||
| Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist | Q47421203 | ||
| Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. | Q47724311 | ||
| Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. | Q47900177 | ||
| Blood BDNF concentrations reflect brain-tissue BDNF levels across species | Q48138873 | ||
| Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia | Q48176460 | ||
| Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology | Q48397485 | ||
| Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes | Q48447557 | ||
| Effects of corticosterone treatment and rehabilitation on the hippocampal formation of neonatal and adult rats. An unbiased stereological study | Q48452206 | ||
| Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets | Q48528817 | ||
| Regulation of Neurotrophin mRNA Expression in the Rat Brain by Glucocorticoids | Q48551826 | ||
| Evaluating the comparability of gene expression in blood and brain | Q48623627 | ||
| Hippocampal volume in women victimized by childhood sexual abuse | Q48669613 | ||
| Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses | Q48752188 | ||
| Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. | Q48967630 | ||
| Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report. | Q51706742 | ||
| Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology. | Q51897104 | ||
| The childhood experience of care and abuse questionnaire (CECA.Q): validation in a community series. | Q51923075 | ||
| Reciprocal actions of interleukin-6 and brain-derived neurotrophic factor on rat and mouse primary sensory neurons. | Q52166978 | ||
| Psychosis and brain volume changes during the first five years of schizophrenia | Q60610021 | ||
| The List of Threatening Experiences: the reliability and validity of a brief life events questionnaire | Q68918765 | ||
| Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia | Q80745048 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psychosis | Q170082 |
| P304 | page(s) | 1677-1684 | |
| P577 | publication date | 2011-05-18 | |
| P1433 | published in | The Journal of Clinical Psychiatry | Q7743563 |
| P1476 | title | Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume | |
| P478 | volume | 72 |
| Q36600804 | A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia |
| Q50574430 | A magnetic resonance imaging family study of cortical thickness in schizophrenia. |
| Q37446818 | A systematic review of cognitive function in first-episode psychosis, including a discussion on childhood trauma, stress, and inflammation |
| Q52645449 | Adjunctive nutrients in first-episode psychosis: A systematic review of efficacy, tolerability and neurobiological mechanisms. |
| Q35603078 | Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis |
| Q38759421 | Altering the course of schizophrenia: progress and perspectives |
| Q26796602 | Alzheimer's Disease associated with Psychiatric Comorbidities |
| Q88616942 | An Overview of Animal Models Related to Schizophrenia |
| Q52692011 | Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis. |
| Q57403239 | Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis |
| Q36377832 | BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year. |
| Q44897333 | Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes |
| Q26752612 | Biomarkers for drug development in early psychosis: Current issues and promising directions |
| Q64933067 | Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation. |
| Q48455050 | Brain-derived neurotrophic factor and inflammatory markers in school-aged children with early trauma |
| Q36902843 | Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury. |
| Q37983548 | Can genetics inform the management of cognitive deficits in schizophrenia? |
| Q26770197 | Cardiometabolic risk factors in young people at ultra-high risk for psychosis: A systematic review and meta-analysis |
| Q37015325 | Childhood adversities and psychosis: evidence, challenges, implications |
| Q24629111 | Childhood exposure to violence and lifelong health: clinical intervention science and stress-biology research join forces |
| Q40746465 | Childhood maltreatment and transition to psychotic disorder independently predict long-term functioning in young people at ultra-high risk for psychosis. |
| Q33845034 | Childhood maltreatment is associated with increased body mass index and increased C-reactive protein levels in first-episode psychosis patients. |
| Q60545809 | Childhood trauma and functional disability in psychosis, bipolar disorder and borderline personality disorder: a review of the literature |
| Q38074731 | Childhood trauma as a cause of psychosis: linking genes, psychology, and biology. |
| Q38646805 | Cognitive Impairment in Schizophrenia: Interplay of BDNF and Childhood Trauma? A Review of Literature |
| Q36189837 | Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. |
| Q35950801 | Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis |
| Q37001281 | Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study |
| Q55070204 | Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms. |
| Q47853926 | Decreased Serum Levels of Ghrelin and Brain-Derived Neurotrophic Factor in Premenopausal Women With Metabolic Syndrome |
| Q38898192 | Depression and Schizophrenia: Cause, Consequence, or Trans-diagnostic Issue? |
| Q50531989 | Depressive Symptom Dimensions and Their Association with Hippocampal and Entorhinal Cortex Volumes in Community Dwelling Older Adults. |
| Q92197348 | Differential gene expression analysis in blood of first episode psychosis patients |
| Q48727133 | Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis |
| Q36024169 | Do child abuse and maltreatment increase risk of schizophrenia? |
| Q47352837 | Dose-Response Association Between Physical Activity and Cognitive Function in a National Sample of Older Adults |
| Q58213863 | Early Life Stress Associated With Increased Striatal -Acetyl-Aspartate: Cerebrospinal Fluid Corticotropin-Releasing Factor Concentrations, Hippocampal Volume, Body Mass and Behavioral Correlates |
| Q55517785 | Effects of a 6-week, whole-body vibration strength-training on depression symptoms, endocrinological and neurobiological parameters in adolescent inpatients experiencing a major depressive episode (the "Balancing Vibrations Study"): study protocol f |
| Q38565570 | Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? |
| Q39001201 | Elevation of C-reactive protein level and its correlation with psychiatric comorbidities in recipients after liver transplantation. |
| Q54258689 | Estrogen receptor-β of microglia underlies sexual differentiation of neuronal protection via ginsenosides in mice brain. |
| Q97692727 | Exercise as a protective mechanism against the negative effects of oxidative stress in first-episode psychosis: a biomarker-led study |
| Q57743238 | Exercise effects on cognitive functioning in young adults with first-episode psychosis: FitForLife |
| Q54439835 | From stress to psychosis: whom, how, when and why? |
| Q36930839 | Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia |
| Q38373219 | Glia-related genes and their contribution to schizophrenia |
| Q48947277 | Hair cortisol in drug-naïve first-episode individuals with psychosis |
| Q41271064 | Impaired fornix-hippocampus integrity is linked to peripheral glutathione peroxidase in early psychosis |
| Q92648329 | Improving Cognition via Exercise (ICE): Study Protocol for a Multi-Site, Parallel-Group, Single-Blind, Randomized Clinical Trial Examining the Efficacy of Aerobic Exercise to Improve Neurocognition, Daily Functioning, and Biomarkers of Cognitive Cha |
| Q43444866 | Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia |
| Q34248044 | Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions. |
| Q27002489 | Inflammation and schizophrenia |
| Q30236016 | Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization |
| Q60644228 | Inflammation: its role in schizophrenia and the potential anti-inflammatory effects of antipsychotics |
| Q38208771 | Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors |
| Q38138169 | Inflammatory cytokine network in schizophrenia |
| Q44801018 | Integrated models in psychiatry: the state of the art. |
| Q57039667 | Intergenerational transmission of depression: clinical observations and molecular mechanisms |
| Q36299394 | Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain |
| Q47155489 | Interleukin-6 in Schizophrenia-Is There a Therapeutic Relevance? |
| Q47903993 | Interplay of hippocampal volume and hypothalamus-pituitary-adrenal axis function as markers of stress vulnerability in men at ultra-high risk for psychosis. |
| Q57148696 | Modeling and estimating the feedback mechanisms among depression, rumination, and stressors in adolescents |
| Q33353554 | Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease? |
| Q37103318 | Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia |
| Q39076734 | Prefrontal Cortex Dysfunction Increases Susceptibility to Schizophrenia-Like Changes Induced by Adolescent Stress Exposure |
| Q27324499 | Probiotic modulation of the microbiota-gut-brain axis and behaviour in zebrafish |
| Q37198098 | Progression from selective to general involvement of hippocampal subfields in schizophrenia |
| Q35844279 | Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder |
| Q33560201 | Relationship between Interleukin-6 gene polymorphism and hippocampal volume in antipsychotic-naïve schizophrenia: evidence for differential susceptibility? |
| Q57513593 | Schizophrenia patients with a history of childhood trauma have a pro-inflammatory phenotype |
| Q36910378 | Serum and gene expression profile of cytokines in first-episode psychosis |
| Q30364687 | Social Stress and Psychosis Risk: Common Neurochemical Substrates? |
| Q26771607 | Stress-Related Immune Markers in Depression: Implications for Treatment |
| Q36063627 | Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia |
| Q34432560 | Temporal-lobe morphology differs between healthy adolescents and those with early-onset of depression |
| Q47140989 | The association between gene variants and longitudinal structural brain changes in psychosis: a systematic review of longitudinal neuroimaging genetics studies |
| Q35502548 | The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link? |
| Q26865996 | The cytokine model of schizophrenia: emerging therapeutic strategies |
| Q34047983 | The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis |
| Q46897663 | The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia |
| Q38436088 | The impact of childhood adversity on the persistence of psychotic symptoms: a systematic review and meta-analysis. |
| Q24067152 | The myth of schizophrenia as a progressive brain disease |
| Q35743326 | The neurobiological correlates of childhood adversity and implications for treatment. |
| Q38809444 | Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions |
| Q26860217 | Translating the MAM model of psychosis to humans |
| Q38955208 | Trauma and the psychosis spectrum: A review of symptom specificity and explanatory mechanisms |
| Q30370012 | Western High-Fat Diet Consumption during Adolescence Increases Susceptibility to Traumatic Stress while Selectively Disrupting Hippocampal and Ventricular Volumes |
| Q97652739 | Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study |
Search more.